Home / Platforms  / CGEn

CGEn is a federally funded national platform for genome sequencing and analysis. Established in 2014, CGEn employs over 200 staff, and is funded primarily by the Canada Foundation for Innovation (CFI) through its Major Science Initiatives Fund (MSI), leveraging investments from Genome Canada and other stakeholders. CGEn operates as an integrated national platform with nodes here at the McGill Genome Centre, as well as in Toronto (The Centre for Applied Genomics at The Hospital for Sick Children), and Vancouver (Canada’s Michael Smith Genome Sciences Centre), providing genomic services, including genome sequencing and analysis, that enable research in agriculture, forestry, fishery, the environment, health sciences, and many other disciplines of interest to Canadians.

CanSeq150 program will lay the foundation for Canada’s next 150 years of science.

To commemorate the 150th Birthday of Canada in 2017 and to lay the foundation of Canadian excellence in research for the next 150 years, Canada’s Genomics Enterprise (CGEn) and its partners are embarking upon the Canada 150 Sequencing Initiative (CanSeq150). The aim is to sequence 150 new genomes to support sequence-based genomics research in Canada by enabling future research in biodiversity and conservation, applications in breeding and biomedicine, as well as technology development, across Canada.

The genomes to be sequenced will be chosen by allowing the research community to nominate and present a case for their species of choice, in a rapid peer-reviewed, competitive process. The results of the competitive review will be made public after the completion of the selection process, along with some genomes proposed by CGEn scientists and collaborators. The genome sequences generated will be made available to researchers worldwide through the most relevant databases including the newly announced Canadian Genomic Cloud resource.